» Articles » PMID: 2670337

Carnitine: Metabolism and Clinical Chemistry

Overview
Journal Clin Chim Acta
Specialty Biochemistry
Date 1989 Jul 31
PMID 2670337
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In man carnitine is synthesized from proteic trimethyllysine in liver, brain and kidney. Muscles which contain approximately 98% of carnitine must take it up from the blood in an exchange process with endogenous deoxycarnitine, the immediate precursor of carnitine. Uneven organ distribution of the enzymes catalyzing carnitine synthesis further implies an inter-organ transport of the intermediates. Assay of these intermediates in blood may assist causal definition of carnitine deficiency syndromes. Besides catalyzing the transport of long-chain acyls in mitochondria, carnitine is necessary for the export of intra-mitochondrially produced short-chain acyls and for trapping and elimination of unphysiological acyls (benzoic, pivalic, valproic acids etc.). Unlike the corresponding acyl-CoA, carnitine esters are capable of diffusing across cellular membranes, and may be eliminated in urine, distributed in tissues or both. Assay of physiological and unphysiological carnitine esters in urine is necessary for the diagnosis of carnitine insufficiencies.

Citing Articles

Multiomics reveals multilevel control of renal and systemic metabolism by the renal tubular circadian clock.

Bignon Y, Wigger L, Ansermet C, Weger B, Lagarrigue S, Centeno G J Clin Invest. 2023; 133(8).

PMID: 36862511 PMC: 10104904. DOI: 10.1172/JCI167133.


L-Carnitine as a Diet Supplement in Patients With Type II Diabetes.

Karalis D, Karalis T, Karalis S, Kleisiari A Cureus. 2020; 12(5):e7982.

PMID: 32523839 PMC: 7273356. DOI: 10.7759/cureus.7982.


L-carnitine protects C2C12 cells against mitochondrial superoxide overproduction and cell death.

Le Borgne F, Ravaut G, Bernard A, Demarquoy J World J Biol Chem. 2017; 8(1):86-94.

PMID: 28289521 PMC: 5329717. DOI: 10.4331/wjbc.v8.i1.86.


Branched chain amino acids chronic treatment and muscular exercise performance in athletes: a study through plasma acetyl-carnitine levels.

De Palo E, Metus P, Gatti R, Previti O, Bigon L, De Palo C Amino Acids. 2013; 4(3):255-66.

PMID: 24190607 DOI: 10.1007/BF00805827.


Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease.

Lodi A, Tiziani S, Khanim F, Gunther U, Viant M, Morgan G PLoS One. 2013; 8(2):e56422.

PMID: 23431376 PMC: 3576408. DOI: 10.1371/journal.pone.0056422.